Kodiak Sciences Inc (KOD)
9.11
-0.46
(-4.81%)
USD |
NASDAQ |
Jan 08, 13:11
Kodiak Sciences Research and Development Expense (Annual): 206.30M for Dec. 31, 2023
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Pfizer Inc | 10.68B |
| Regeneron Pharmaceuticals Inc | 4.439B |
| Revance Therapeutics Inc | 79.41M |
| Editas Medicine Inc | 177.65M |
| Arcutis Biotherapeutics Inc | 110.58M |